Form D - Notice of Exempt Offering of Securities:
SEC Accession No. 0001807611-20-000001
Filing Date
2020-04-08
Accepted
2020-04-08 10:40:22
Documents
1
Effectiveness Date
2020-04-08
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D  
1 primary_doc.xml D 11256
  Complete submission text file 0001807611-20-000001.txt   12315
Mailing Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451
Business Address 303 WYMAN STREET SUITE 300 WALTHAM MA 02451 617-415-5030
Regenacy Pharmaceuticals, Inc. (Filer) CIK: 0001807611 (see all company filings)

EIN.: 611807806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D | Act: 33 | File No.: 021-364531 | Film No.: 20781381